Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Abstract Long-term effects of continuous subcutaneous apomorphine infusion (CSAI) on health-related quality of life (HRQoL) and predictors of CSAI discontinuation are poorly known. Data from consecutive advanced Parkinson’s disease patients treated in routine care were retrospectively collected over...

Full description

Bibliographic Details
Main Authors: Bruna Meira, Bertrand Degos, Elise Corsetti, Mohamed Doulazmi, Emeline Berthelot, Clara Virbel-Fleischman, Pauline Dodet, Aurélie Méneret, Louise-Laure Mariani, Cécile Delorme, Florence Cormier-Dequaire, David Bendetowicz, Nicolas Villain, Clément Tarrano, Lise Mantisi, Hélène Letrillart, Céline Louapre, Eavan McGovern, Yulia Worbe, David Grabli, Marie Vidailhet, Elodie Hainque, Emmanuel Roze
Format: Article
Language:English
Published: Nature Portfolio 2021-06-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-021-00194-7

Internet

https://doi.org/10.1038/s41531-021-00194-7

Similar Items